Receive 30% off all Monoclonal IHC antibodies with code "MONO-IHC-30"! Offer valid for US customers and available internationally through distributors.

Recombinant human EPOR protein, C-His (HEK293), APC Conjugated

Applications

  • Others

Reactivity

  • Others
Overview
Catalog # bs-43588P-APC-100ug
Product Name Recombinant human EPOR protein, C-His (HEK293), APC Conjugated
Applications Others
Reactivity Others
Specifications
Conjugation APC
Source Recombinant human EPOR protein is expressed in HEK293 cell with C-His. It contains the amino acid sequence of 25-250/508
Storage Buffer Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Target
Swiss Prot P19235
Background The erythropoietin receptor (EPOR) is a member of the cytokine receptor family. There are several isoforms including: EPOR-F (full length), EPOR-S (soluble form), and EPOR-T (truncated form). Upon erythropoietin (EPO) binding, the EPOR activates Jak2 tyrosine kinase which activates different intracellular pathways including: Ras/MAP kinase, phosphatidylinositol 3-kinase and STAT transcription factors. The stimulated EPOR appears to have a role in erythroid cell survival. Defects in the EPOR may produce erythroleukemia and familial erythrocytosis. A functional EPOR is found in the cardiovascular system, including endothelial cells and cardiomyocytes, and data suggest that the EPO/EPO receptor system plays an important role in cardiac function. In animal studies, treatment with EPO during ischemia/reperfusion in the heart has been shown to limit the infarct size and the extent of apoptosis.